Katherine Stueland sold $638K of GeneDx (WGS)

Executed Jun 16, disclosed Jun 18, 2 days later.

Value, as filed

$638K

10,501 sh across 3 lots

Executed

Jun 16

the trade date, as filed

Disclosed

Jun 18

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Katherine Stueland Chief Executive Officer profile →

Katherine Stueland (Chief Executive Officer) filed 14 Form 4 reports in the trailing twelve months (0 purchases, 14 sales), most often in GeneDx Holdings Corp. (WGS). The largest single filing was $3.0M of WGS (46,933 sh across 5 lots, as filed), executed Mar 26.

The name

WGS

GeneDx Holdings Corp. WGS · Healthcare · 69 filings in 24 months ticker →

Healthcare · GeneDx Holdings Corp., a genomics company, provides genetic testing services

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Katherine Stueland in WGS

WGSSALE GeneDx Holdings Corp. $1.0M
10,353 sh across 4 lots
Exec Sep 16
Filed Sep 18 · 4:43 PM ET WGSSALE GeneDx Holdings Corp. $311K
3,692 sh × $84.22
Exec Sep 9
Filed Sep 11 · 4:13 PM ET WGSSALE GeneDx Holdings Corp. $196K
3,639 sh × $53.77
Exec Jun 9
Filed Jun 11 · 5:30 PM ET WGSSALE GeneDx Holdings Corp. $140K
2,154 sh × $65.20
Exec Apr 29
Filed May 1 · 5:30 PM ET WGSSALE GeneDx Holdings Corp. $3.0M
46,933 sh across 5 lots
Exec Mar 26
Filed Mar 30 · 5:30 PM ET WGSSALE GeneDx Holdings Corp. $1.3M
16,407 sh across 2 lots
Exec Mar 16
Filed Mar 17 · 5:30 PM ET WGSSALE GeneDx Holdings Corp. $319K
3,678 sh × $86.75
Exec Mar 9
Filed Mar 11 · 5:30 PM ET WGSSALE GeneDx Holdings Corp. $2.0M
25,459 sh across 3 lots
Exec Mar 4
Filed Mar 5 · 5:30 PM ET